Eribulin Mesylate

BluePoint Laboratories🇺🇸 United States

FDA Page

Effective Date: Mar 25, 2026
Approval ID: 1a1a9cff-d5da-4232-b98f-26f55208dfc4
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ERIBULIN MESYLATE INJECTION safely and effectively. See full prescribing information for ERIBULIN MESYLATE INJECTION. ERIBULIN MESYLATE INJECTION, for intravenous use Initial U.S. Approval: 2010

Quick Stats

Total Products1

Labelers1

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.